Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anetta Undas

Showing results (531-540 of 652) with videos related to

Pageof 66
Sort By:
Neuro Endocrinology Letters|June 15, 2011
Aspirin resistance may be associated with adverse pregnancy outcomesAnna Wójtowicz, Anetta Undas, Hubert Huras, et al.
Thrombosis and Haemostasis|August 23, 2005
Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemiaAnetta Undas, Magdalena Celinska-Löwenhoff, Teresa B Domagala, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|May 9, 2019
Increased activity of lipoprotein-associated phospholipase A<sub>2</sub> in non-severe asthmaPawel Kuczia, Lucyna Mastalerz, Daniel P Potaczek, et al.
Thrombosis and Haemostasis|February 6, 2010
Characterisation of a novel nonsense mutation in FGG (Fibrinogen Poznan) causing hypofibrinogenaemia with a mild bleeding tendencyKrystyna Zawilska, Anetta Undas, Richard J Fish, et al.
Inflammation|September 22, 2011
Does diabetes accelerate the progression of aortic stenosis through enhanced inflammatory response within aortic valves?Joanna Natorska, Ewa Wypasek, Grzegorz Grudzień, et al.
Thrombosis and Haemostasis|January 4, 2019
Plasma Protein Oxidation as a Determinant of Impaired Fibrinolysis in Type 2 DiabetesAgata H Bryk, Malgorzata Konieczynska, Pawel Rostoff, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 28, 2005
Simvastatin given for 3 days can inhibit thrombin generation and activation of factor V and enhance factor Va inactivation in hypercholesterolemic patientsAnetta Undas, Magdalena Celinska-Löwenhoff, Kathleen E Brummel-Ziedins, et al.
Indian Heart Journal|January 1, 2017
Preoperative values of inflammatory markers predict clinical outcomes in patients after CABG, regardless of the use of cardiopulmonary bypassDariusz Plicner, Jarosław Stoliński, Marcin Wąsowicz, et al.
Kardiologia Polska|July 25, 2012
Platelet activation and microvascular injury in patients with ST-segment elevation myocardial infarctionJarosław Zalewski, Monika Durak, Piotr Lech, et al.
Thrombosis and Haemostasis|May 1, 2009
Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and functionAnetta Undas, Joanna Zdziarska, Teresa Iwaniec, et al.
Pageof 66

Showing results (531-540 of 652) with videos related to

Sort By:
Pageof 66
Neuro Endocrinology Letters|June 15, 2011
Aspirin resistance may be associated with adverse pregnancy outcomesAnna Wójtowicz, Anetta Undas, Hubert Huras, et al.
Thrombosis and Haemostasis|August 23, 2005
Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemiaAnetta Undas, Magdalena Celinska-Löwenhoff, Teresa B Domagala, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|May 9, 2019
Increased activity of lipoprotein-associated phospholipase A<sub>2</sub> in non-severe asthmaPawel Kuczia, Lucyna Mastalerz, Daniel P Potaczek, et al.
Thrombosis and Haemostasis|February 6, 2010
Characterisation of a novel nonsense mutation in FGG (Fibrinogen Poznan) causing hypofibrinogenaemia with a mild bleeding tendencyKrystyna Zawilska, Anetta Undas, Richard J Fish, et al.
Inflammation|September 22, 2011
Does diabetes accelerate the progression of aortic stenosis through enhanced inflammatory response within aortic valves?Joanna Natorska, Ewa Wypasek, Grzegorz Grudzień, et al.
Thrombosis and Haemostasis|January 4, 2019
Plasma Protein Oxidation as a Determinant of Impaired Fibrinolysis in Type 2 DiabetesAgata H Bryk, Malgorzata Konieczynska, Pawel Rostoff, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 28, 2005
Simvastatin given for 3 days can inhibit thrombin generation and activation of factor V and enhance factor Va inactivation in hypercholesterolemic patientsAnetta Undas, Magdalena Celinska-Löwenhoff, Kathleen E Brummel-Ziedins, et al.
Indian Heart Journal|January 1, 2017
Preoperative values of inflammatory markers predict clinical outcomes in patients after CABG, regardless of the use of cardiopulmonary bypassDariusz Plicner, Jarosław Stoliński, Marcin Wąsowicz, et al.
Kardiologia Polska|July 25, 2012
Platelet activation and microvascular injury in patients with ST-segment elevation myocardial infarctionJarosław Zalewski, Monika Durak, Piotr Lech, et al.
Thrombosis and Haemostasis|May 1, 2009
Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and functionAnetta Undas, Joanna Zdziarska, Teresa Iwaniec, et al.
Pageof 66